Annual accounts
Small accounts
30/04/2027Filing deadline
Made up to 31/07/2025Due 30/04/2027
- Next accounts made up to
- 31/07/2026
- Last accounts made up to
- 31/07/2025
INFEX THERAPEUTICS LIMITED
Active- 09990238Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Mereside, Alderley Park, Macclesfield SK10 4TG
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Small
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 11/02/2026View PDF (3 pages)
Confirmation statement made on 2026-01-30 with no updates
- 30/10/2025View PDF (9 pages)
Accounts for a small company made up to 2025-07-31
- 10/02/2025View PDF (3 pages)
Confirmation statement made on 2025-01-30 with no updates
- 19/12/2024View PDF (9 pages)
Accounts for a small company made up to 2024-07-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 30/01/2027
- Last statement dated
- 31/07/2025
Financial performance
The latest figures INFEX THERAPEUTICS LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£-1.84M2025
81.70%vs 20242024: £-10.05M
Total Assets
£771.84K2025
-25.19%vs 20242024: £1.03M
Cash in Bank
£97.12K2025
-19.50%vs 20242024: £120.66K
Total Liabilities
£2.61M2025
-76.44%vs 20242024: £11.08M
Employees
242025
+2vs 20242024: 22
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Total liabilities moved furthest, down 76.44% on 2024. See the full financial analysis for INFEX THERAPEUTICS LIMITED.
The full financial record
Four ways through INFEX THERAPEUTICS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · -39.2% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 24 | +2 |
| 2024 | 22 | 0 |
| 2023 | 22 | -1 |
| 2022 | 23 | -1 |
| 2021 | 24 | – |
Reported employee count was unchanged at 24 between 2021 and 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
10Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 19/07/2017–12/05/2022 | 15 | |
| Director | 05/02/2016–Present | 15 | |
| Director | 06/09/2016–Present | 127 | |
| Director | 21/03/2019–18/05/2021 | 4 | |
| Director | 06/09/2016–11/04/2017 | 6 | |
| Director | 06/09/2016–29/03/2019 | 10 | |
| Director | 18/10/2019–11/08/2021 | 11 | |
| Director | 06/09/2016–Present | 7 | |
| Secretary | 05/02/2016–12/12/2017 | 0 | |
| Director | 01/02/2023–Present | 1 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 05/04/2022–Present | 0 | |
| 04/02/2017–19/07/2017 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 13 Since 18/10/2022
- Last 12 months
- 2 -2 vs the year before
- Most recent filing
- 11/02/2026 7 months ago
What changed in the last year
- Confirmation statementLatest 11/02/2026
- Accounts filedLatest 30/10/2025
Filing timeline
- 11/02/2026View PDF (3 pages)
Confirmation statement made on 2026-01-30 with no updates
- 30/10/2025View PDF (9 pages)
Accounts for a small company made up to 2025-07-31
- 10/02/2025View PDF (3 pages)
Confirmation statement made on 2025-01-30 with no updates
- 19/12/2024View PDF (9 pages)
Accounts for a small company made up to 2024-07-31
- 05/12/2024View PDF (1 pages)
Satisfaction of charge 099902380002 in full
- 05/12/2024View PDF (1 pages)
Satisfaction of charge 099902380001 in full
- 30/01/2024View PDF (3 pages)
Confirmation statement made on 2024-01-30 with no updates
- 27/10/2023View PDF (49 pages)
Registration of charge 099902380002, created on 2023-10-18
- 23/10/2023View PDF (9 pages)
Accounts for a small company made up to 2023-07-31
- 09/02/2023View PDF (5 pages)
Confirmation statement made on 2023-02-04 with updates
- 07/02/2023View PDF (2 pages)
Change of details for Infex Therapeutics Holdings Limited as a person with significant control on 2022-05-05
- 05/02/2023View PDF (2 pages)
Appointment of Professor Colm Leonard as a director on 2023-02-01
Showing 12 of 13 filings
See when the next accounts and confirmation statement are due
Similar companies
34 UK companies are similar to INFEX THERAPEUTICS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
CERES HOLOGRAPHICS LIMITED
ActiveSuite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh EH4 2HS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- SC330746
- Incorporated
- 11/09/2007
- Employees
- 22
WEATHERDEN LIMITED
Active264 Banbury Road, Oxford OX2 7DY
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09241011
- Incorporated
- 30/09/2014
- Employees
- 29
LIVER RESEARCH AND DEVELOPMENT LIMITED
Active111 Coldharbour Lane, London SE5 9NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 07944232
- Incorporated
- 09/02/2012
- Employees
- 21
A.M.S. BIOTECHNOLOGY (EUROPE) LIMITED
ActiveMunro House Trafalgar Way, Bar Hill, Cambridge CB23 8SQ
- Activity
- Research and experimental development on biotechnology
- Company no.
- 02117791
- Incorporated
- 31/03/1987
- Employees
- 22
BIODIVERSIFY LTD
Active6 Great North Road, Cromwell, Newark, Nottinghamshire NG23 6JE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11352631
- Incorporated
- 09/05/2018
- Employees
- 21
About INFEX THERAPEUTICS LIMITED
A short description of the company, written from its Companies House record.
INFEX THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, based in Mereside, Alderley Park, Macclesfield SK10 4TG. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 10 years 7 months.
The register currently records it as active. Its 2025 accounts report net assets of £-1.84M and 24 employees.
INFEX THERAPEUTICS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does INFEX THERAPEUTICS LIMITED do?
Companies House records INFEX THERAPEUTICS LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is INFEX THERAPEUTICS LIMITED still active?
INFEX THERAPEUTICS LIMITED is recorded as active on the Companies House register, and has been on it since 05/02/2016.
What are INFEX THERAPEUTICS LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £-1.84M, total assets of £771.84K, cash in bank of £97.12K and total liabilities of £2.61M.
When did INFEX THERAPEUTICS LIMITED last file with Companies House?
The most recent document on the record is dated 11/02/2026: Confirmation statement made on 2026-01-30 with no updates, 7 months ago.
When are INFEX THERAPEUTICS LIMITED's next filings due?
On the current registry record, accounts are due by 30/04/2027.
Who runs INFEX THERAPEUTICS LIMITED?
Companies House lists 10 officers (4 currently in post) and 2 people with significant control (1 current).